Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Okafor

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized TrialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized TrialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Pageof 2